US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing ...

Portuguese biotech FairJourney Biologics has acquired South San Francisco antibody R&D facility from Charles River Labs, ...

Researchers from Sanofi SA reported the preclinical characterization of SAR-446159 (ABL-301), a bispecific antibody construct comprising an antibody targeting α-synuclein fused to an engineered ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

Different types of antibodies are produced by your immune system. These five antibodies help fight disease by detecting viruses, bacteria, and other pathogens (disease-causing microorganisms) and ...

SFJ Pharmaceuticals (SFJ) and (SERB) announced today the final results of the pivotal Phase 3 REVERSE-IT trial designed to study ...

A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.

today announced positive preclinical results for its novel oral antibody, TH023. In a murine model, a proprietary protease enzyme stabilized platform demonstrated successful delivery of infliximab ...

BRIDGEWATER, NJ / ACCESS Newswire / March 24, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company focused on immunology and inflammation ...

Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven 5612 AE, the Netherlands Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, ...

Alternatively, immunoassay that exploit antigen-antibody interactions ... The single chain variable fragment (scFv) gene of TS77 was synthesized and cloned into the pUC57 (Shanghai Sangon Biotech Co., ...